Join us from November 29 to December 1, 2025, for three days of cutting-edge sessions, expert talks, and interactive discussions across four dynamic programs: Vascular ART Main Auditorium, Round Table Discussion, Vascular ART Theater, and Limb Rescue Room.
A PDF version of the program will be available soon
Moderator: Martin Storck-Germany- Ashraf Hedayet Egypt
Time
Topic
Speaker
15:00- 15:15
Who Really Is “No-Go” for Surgery? – Defining High-Risk in 2025
How do we define inoperability in the era of advanced anesthesia and hybrid approaches?
Role of scoring systems (e.g., SAPPHIRE) vs. clinical judgment.
Are some "no-go" patients actually "no-try"?
Hattan Alghamdi -KSA
15:15- 15:30
Carotid Artery Stenting (CAS) in High-Risk Patients – Still a Reasonable First Line?
Current evidence on CAS outcomes in symptomatic high-risk patients
Device evolution: Embolic protection, closed-cell vs. open-cell stents
Can we personalize the decision beyond anatomy?
krzysztof szaniewski- Poland
15:30- 15:45
High risk patients undergoing carotid surgery: What do we have to consider?
Martin Storck-Germany
15:45- 16:00
Medical Management Alone – Still a Valid Option in 2025?
For patients who can’t tolerate or refuse revascularization
Role of dual antiplatelets, statins, and plaque stabilization
Risk stratification for stroke recurrence under conservative management
krzysztof szaniewski- Poland
Michael Kallmeyer-Germany
Martin Storck-Germany
Who Really Qualifies for DVA? – Patient Selection in No-Option CLI
Clear indications and gray zones: when is DVA justified?
Angio some concept vs. global foot perfusion?
Role of WIFI, GLASS, and PROMISE II criteria?
Hany Zayed-UK
11:15- 11:30
Beyond DVA: Alternative Tools for No-Option Critical Limb Ischemia
• Alternative endovascular tools and methods:
• Deep peroneal or pedal loop recanalization
• Collateral channel angioplasty (Safari, reverse CART)
• Subintimal arterial flossing and re-entry techniques
• Advanced vessel prep (rotational/orbital atherectomy, laser, IVL) in borderline inflow
• Use of microcatheters, retrograde puncture, and combined access
• Adjunctive biologic or wound healing approaches:
• Cell-based or plasma-derived therapies
• Negative pressure wound therapy + angioplasty
Tamer Fouad -Oman/ Mohamed Farouk
11:30- 11:45
Literature Check – What Do the Trials and Registries Say?
PROMISE I ł II, APEX, ALPS: what are they really telling us?
Patency, limb salvage, wound healing rates
Is there truly a survival benefit in no-option CLI?
Bruno Migliara-Italy
11:45- 12:00
The Follow-Up Challenge – Managing the DVA Patient Beyond the Procedure
Surveillance protocols: clinical, duplex, and imaging
When to intervene on failing flow? When to amputate?
Role of podiatry, wound care, and multidisciplinary teams
Bruno Migliara-Italy
Hany Zayed-UK
Tamer Fouad -Oman
Red Flags After EVAR – When Does “Watchful Waiting” Become Dangerous?
Identifying failure early: sac expansion, Type I/III endoleaks, loss of seal
Role of imaging follow-up: how often and what modality?
Defining “failed EVAR” in clinical practice
Wael Tawfik-Ireland
12:15- 12:30
Salvage Endovascular Tactics – Are We Pushing It Too Far?
Chimney, snorkel, end anchors, relining: tools or desperation?
When to say "enough" with endo-fixation strategies
Are we risking rupture by delaying conversion?
Mohamed Elkassaby -Ireland
12:30- 12:45
The Open Conversion – When, How, and By Whom?
Technical aspects: total vs. partial explant, suprarenal fixation issues
High-risk patient profiles: is open conversion feasible?
The role of hybrid surgeons and tertiary referral centers
Murad Sallam-UK
12:45- 13:00
Guidelines vs. Real Life – Who Sets the Line in the Sand?
What current guidelines recommend – and their limitations
Case-based experience: borderline calls and decision algorithms
Creating institutional protocols for EVAR failure management
Moderator: Michael Lichtenberg-Germany- Ehab Saad Egypt
Time
Topic
Speaker
14:00- 14:15
Landing Zones, Sizing, and Wall Apposition – Are We Getting It Right?
Identifying healthy distal landing zones in post-thrombotic disease
The challenge of “true lumen” tracking in chronic occlusion
IVUS vs. venography for sizing and length determination
In-stent restenosis: sizing errors or biology?
Ahmed gawesh -Egypt
14:15- 14:30
Complex Iliocaval Reconstruction – How Far Can We Go?
Crossing long-standing occlusions: best wires, sheaths, and snaring tricks
Managing iliocaval confluence and May-Thurner overlap
Handling filters, high bifurcations, duplicated systems
Single vs. kissing stents in bilateral disease
Michael Lichtenberg-Germany
14:30- 14:45
Venous Hybrid OR – How to Set It Up for Success
What your Angio room must have: table, access, support staff
Patient positioning, dual access techniques
Tools checklist: from recanalization to ballooning and stenting
Abdullah Abdullah - KSA
14:45- 15:00
Post-Stenting Protocols and Pitfalls – What Should We All Be Doing?
Anticoagulation and antiplatelet strategy: is there a consensus?
Surveillance: when, how often, and with what imaging?
Re-thrombosis, mis deployment, kinking – how to avoid and manage
When to reintervene vs. wait-and-see: literature vs. experience
Ahmed gawesh -Egypt
Michael Lichtenberg-Germany
Abdullah Abdullah KSA
Uncomplicated Type B: Surveillance or Preemptive TEVAR?
Updated guidelines: when is “uncomplicated” really safe?
Predictors of late aneurysmal degeneration: who’s at risk?
Is early TEVAR reshaping long-term outcomes?
Role of dynamic imaging in early risk stratification
David Wells-UK
15:15- 15:30
The Shearing Zone: Managing the Bird-Beak and Arch Challenges
Importance of proximal landing zones in the arch (Zone 2/3)
Bird-beak configuration: predictors and solutions
Role of left subclavian artery management (revascularization or coverage?)
New stent-graft technologies for better arch apposition
Mohamed Shaltout -KSA
15:30- 15:45
Fenestration , Petticoat , Distal Perfusion , What works Best ?
PETTICOAT technique: still relevant or outclassed?
Endovascular adjuncts for distal true lumen expansion
Combining TEVAR with distal bare stents: evidence and technique .
Ali Badra -France
15:45- 16:00
When TEVAR fails or not Enough ? What are the other Option?
Persistent male perfusion: when to escalate Open conversion: when and how to plan
Complications post-TEVAR: retrograde dissection, endoleaks, stent-induced injury
Life after TEVAR: imaging surveillance, reintervention planning
Moderator: Giuseppe Papia-Canada – M Ayman Fakhry Egypt
Time
Topic
Speaker
16:30- 16:45
Acute DVT: Who Benefits from Early Intervention?
Recent clinical models stratification for selecting patients for endovascular vs. medical therapy.
When thrombolysis, thrombectomy, or hybrid approaches make a difference.
Should iliofemoral DVT always prompt a more aggressive approach?
Mohamed Hagag-Egypt
16:45- 17:00
Filters in the Modern Era: Still a Place or Phasing Out?
Current guideline recommendations: IVC filter indications and retrieval timelines.
Are we overusing filters in fear of PE?
Innovations in retrievable and bio convertible filters — what's changing?
Ahmed Gawesh-Egypt
17:00- 17:15
PTS Prevention and Management: Are We Failing?
What role do endovascular tools play in reducing long-term PTS?
The role of compression, ambulation, and anticoagulation: do we have the right protocols?
Updates on scoring systems and objective PTS assessment
Atef Abdelhamid-Egypt
17:15- 17:30
Anticoagulation and Antiplatelets in DVT/PTS: One Size Fits All?
NOACs in DVT: Are they enough in preventing PTS or recurrence?
Is there a role for dual therapy (anticoagulants + antiplatelets) in certain cases? Duration of therapy — how long is long enough?
